3 results with a keyword:
|REVOFIL AQUASHINE SOFT FILLER||Europe||from $81.00 USD||product info|
|REVOFIL AQUASHINE BR SOFT FILLER||Europe||from $81.00 USD||product info|
|REVOFIL AQUASHINE BTX||Europe||from $81.00 USD||product info|
Revofil is a line of hyaluronic acid-based dermal fillers offered by Caregen, a South Korean pharmaceutical company. These fillers help control age-related concerns that show on the face, including fine lines, wrinkles, as well as volume loss. In addition, these injectables are also useful in remodeling facial contours.
This brand consists of 2 types of injectables, made either of cross-linked or linear hyaluronic acid. Fine, Plus, and Ultra serve to fill lines and wrinkles and add volume to the face. Aquashine and AquashineBR are 2 injectables made of non-crosslinked hyaluronic acid which are used for facial rejuvenation.
These dermal fillers employ the use of cutting edge technology to produce a gel that is superior to other hyaluronic acid dermal fillers in terms of longevity and durability of results. With extensive biomedical and clinical research, these fillers are proven in their efficacy and ability to deliver younger looking skin.
Suitable candidates for a Revofil treatment are patients above the age of 18 who are exhibiting minor signs of aging on their facial skin, such as wrinkles and sagging skin due to volume loss. These individuals should not have sensitivities to hyaluronic acid or its derivatives. These fillers are contraindicated in pregnant women, lactating mothers, and in children under the age of 18.
Over time, various external factors such as age, pollution, diet and lifestyle may cause skin to age prematurely. Typical indicators of aging skin such as fine lines and wrinkles, loss of volume in the face resulting in sunken eyes and cheekbones, and dehydrated, dull skin all lead to a haggard, timeworn appearance. Revofil helps lessen the effects of premature aging by restoring lost volume to the face, which assists in physically smoothing out the skin to correct depressions, while also tightening the skin to redefine the facial features.
These dermal fillers contain hyaluronic acid and a proprietary peptide complex which serves to promote collagen growth. The peptide complex is made up of “biomimetic peptides,” which are synthetic oligopeptides developed by Caregen to mimic the action of naturally occurring stimulants of growth factors in the body. In vitro studies show that these fillers positively regulate (i.e. promotes growth of) native collagen and hyaluronic acid in human fibroblasts cells.
The Aquashine dermal fillers, are a form of mesotherapy that aim to revitalize the skin by improving its dermal structure. AquashineBR is specially formulated to brighten and minimize pigmentation issues, such as age spots and an uneven skin tone.
Revofil injections may only be administered by a trained and licensed physician. The procedure itself takes a short time to complete—about 30-90 minutes in total.
Before beginning treatment, it is imperative to take down the past medical history of the patient and inform them fully of the expected outcome, precautions and potential side effects that may arise from this procedure.
When necessary, apply a local anesthetic before injection for the comfort of the patient. Inject the gel into the determined areas to be treated, stopping occasionally to assess the results. Maintenance treatments should be performed to sustain effects.
With its patented formulation clinically proven to deliver longer lasting results than that of its competitors, this brand of dermal fillers provides the best value when it comes to treatment cost. Treatment with a single injection of Revofil is typically expected to last 10 months to 1 year.
These fillers have undergone extensive and comprehensive testing to evaluate various aspects of its biocompatibility properties, including tests for sterility, endotoxin, skin sensitization, acute toxicity, intradermal reactivity, cytotoxicity, and long-term (12-week) subdermal implantation. Results from these numerous tests were positive, with tissue improvement in most clinical cases and no side effects requiring medical treatment observed.
In the clinical studies done on these products, there have been very little side effects reported. Some typical effects include swelling, pain, or redness at the site of injection. These should subside within 1 week, if these effects persist, the patient should seek immediate medical attention.
There is no recovery time associated with this type of treatment. Your patients will be able to resume their normal daily activities as soon as they’ve completed the treatment.
The prices that patients expect to pay for this type of treatment will differ depending on the type of product, volume used, the practitioner, and geographical region. The average cost of a dermal filler treatment is $644 per syringe.